Open original FDA record ↗Recall record
- FDA identifier
- Z-1132-2021
- Company in FDA record
- LumiraDx
- FDA classification date
- Feb 17, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Observations of potential false positive results in the specified lots. Use of these test strips may result in false positive patient test results and potential exposure to unnecessary treatment or quarantine.
Source facts
- Action
- On 01/28/2021, Lumiradx issued Urgent Medical Device Recall notices to customers via letter notifying customers the potential of false positive results in specified lots of LumiraDx SARS-CoV-2 Antigen (Ag) Test Strip. A false positive test result of a patient could result in potential exposure to unnecessary treatment or quarantine. (Updated 3/15/2021) On 2/26/2021, Lumiradx issued a second Urgent Medical Device Recall notice to customers via letter expanding the recall to include 3 additional lots. These lots are subject to recent feedback from a small number of customers regarding a small to moderate elevation in numbers of reported false positive patient test results.
- Initiated
- 2021-01-11
- Root cause
- Nonconforming Material/Component
- Terminated
- 2021-12-03
- Distribution
- Worldwide distribution. US states of CA, GA, PA, SD. (Updated 3/15/2021) Austria, Germany, Ireland, Italy, Lebanon, Netherlands, Slovenia, Spain, United Kingdom.
- Recall number
- Z-1132-2021
- Recall status
- Terminated
- CDRH record ID
- 185635
- FDA classified
- 2021-02-17
- Recall event number
- 87259